#Non-HodgkinLymphoma
Long-term follow-up of dual CD19/CD22 CAR-T-cell therapy, as #Monotherapy and with autologous #StemCellTransplantation, in TP53-altered relapsed/refractory B-cell non-#HodgkinLymphoma patients, reveals clinical benefit & manageable toxicity.

#OpenAccess: doi.org/10.1038/s413...
February 19, 2026 at 6:06 AM
💡 The National Non-Hodgkin Lymphoma Audit (NNHLA) project team has released the latest update to our quarterly data dashboards 🌟

Visit the dashboards here:
👉 www.natcan.org.uk/reports/nnhl...

#BloodCancer #Non-HodgkinLymphoma #ClinicalAudit #Audit #Data #Datadashboards #NHSE #Hopitals
NNHLA Quarterly Data Dashboard - National Cancer Audit Collaborating Centre
The purpose of the National non-Hodgkin lymphoma Audit (NNHLA) is to evaluate the patterns of care and outcomes for people diagnosed with non-Hodgkin lymphoma (NHL) in England and Wales, and to suppor...
www.natcan.org.uk
April 10, 2025 at 10:22 AM
I’m a lymphoma patient, and I’ve always wondered what made these two types different. So I broke it down in real language — symptoms, treatment, and what I wish I knew at diagnosis.
💜 Watch now: www.youtube.com/watch?v=Gf37...

#Lymphoma #CancerAwareness #NonHodgkinLymphoma #HodgkinLymphoma
Hodgkin’s vs. Non-Hodgkin’s Lymphoma – What’s the Difference?
YouTube video by Thriving with Cancer
www.youtube.com
April 24, 2025 at 8:34 PM